Trial Profile

A retrospective study of Volanesorsen in patients suffering from familial chylomicronemia syndrome (FCS), both before and during treatment periods

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 08 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 May 2024 According to Relay Therapeutics media release, company expects tumor agnostic data and regulatory update in the second half of 2024
02 May 2024 According to Relay Therapeutics media release, company will minimize resource allocation in 2024 to allow data to mature and inform future clinical development decisions
13 Jun 2018 According to an Akcea Therapeutics media release, results from this trial were published in the journal Expert Review of Cardiovascular Therapy.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com